🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07719712
Recruiting Observational

Cognitive Dysfunction and Delirium After TUR-M in Elderly Patients

NCT07719712 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-04-05
Last updated
2026-07-22

Condition(s) studied

Postoperative DeliriumPostoperative Cognitive DysfunctionCognitive Dysfunction

Investigational drug(s) / intervention(s)

Cognitive and Delirium Assessment (MoCA and CAM)

Cognitive and Delirium Assessment (MoCA and CAM): Patients aged 65 years and older undergoing transurethral resection who are followed for the development of postoperative cognitive dysfunction and delirium.

Study summary

Elderly patients undergoing transurethral resection are at increased risk of postoperative cognitive dysfunction (POCD) and delirium, which are associated with prolonged hospital stay, increased morbidity, and decreased quality of life. Identifying patients who are more likely to develop postoperative cognitive dysfunction or delirium remains a practical challenge in daily clinical practice. Better recognition of these patients may help tailor perioperative care and improve outcomes.

This prospective observational study aims to identify perioperative factors associated with POCD and delirium in elderly patients undergoing transurethral resection and to develop a clinically applicable risk prediction model. Cognitive function and delirium are assessed using the Montreal Cognitive Assessment (MoCA) and the Confusion Assessment Method (CAM).

Cognitive function and delirium will be evaluated using the Montreal Cognitive Assessment (MoCA) and the Confusion Assessment Method (CAM).

The results of this study may support clinicians in recognizing vulnerable patients earlier and may contribute to more individualized perioperative management.

Eligibility

Sex
ALL
Min age
65 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥65 years * Scheduled for transurethral resection procedure * ASA physical status I-III * Able to provide informed consent * Adequate cognitive function to complete preoperative assessment Exclusion Criteria: * Pre-existing diagnosis of dementia or severe cognitive impairment (MoCA \<18) * Severe visual or hearing impairment preventing cognitive assessment * History of psychiatric disease requiring antipsychotic or sedative medication * Neurological disorders associated with increased delirium risk (e.g., Parkinson's disease, epilepsy) * Inability to complete study assessments

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Muğla Training and Research Hospital Muğla Turkey (Türkiye) Recruiting

More Muğla Sıtkı Koçman University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07719712 on ClinicalTrials.gov ↗ ← All trials in Turkey